Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity

Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity

US Patent 9168307 · Granted Oct 27, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Preloaded DMEK holder2025
Combination therapy for cancer treatment2025
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate 2024
Poly(diaminosulfide) particle-based vaccine2024
Compositions and methods for treating cancer2023
Compositions and methods for treating cancer2022
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate 2022
MicroRNA-200 based approaches for modulating bone formation inhibition and bone 2020
Methods to prevent or treat periodontitis or peri-implantitis2020
RNA based biomaterial for tissue engineering applications2019
Methods for treating tumors in situ including intratumor injection of cytotoxic 2019
MicroRNA-200 based approaches for modulating bone formation inhibition and bone 2019